| Title | Biomarker data |
|---|---|
| Description | A PHASE 3 MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF ROZANOLIXIZUMAB IN ADULT STUDY PARTICIPANTS WITH PERSISTENT OR CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) |
| Organism | Homo sapiens |
| Data Type | Biomarker Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA013449 |
| Release Date | 2024-12-31 |
| Submitter | Ming Hou (houming@medmail.com.cn) |
| Organization | Qilu Hospital of Shandong University |
| Submission Date | 2022-12-06 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download |
|---|---|---|---|---|---|---|
| OMIX002533-01 | Biomarker data for the screening visit | 1 | Biomarker Data | 28.5 KB | xlsx | Controlled |
| OMIX002533-02 | Biomarker data_unblinded | 1 | Biomarker Data | 29.3 KB | xlsx | Controlled |
| Paper Title | Journal Name | Publish Time | Accession | Citing Type |
|---|